An Anti-viral Pill to Treat Covid?

The video discusses a new COVID-19 drug that inhibits viral replication, showing promise in early-stage treatment. Clinical trials indicate a 50% reduction in hospitalization or death, though the absolute risk reduction is 7%. Safety and cost are key considerations, with potential concerns for fetal development. The drug is most effective when administered early and may be costly for some countries. It is a valuable tool but not a cure-all, emphasizing the need for multiple protective measures, including vaccination.

What concerns were raised regarding the trial participants and fetal development?

Why is it important to have multiple tools in the fight against COVID-19?